Andersen-Tawil syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
(No difference)

Revision as of 19:02, 2 January 2009

Andersen-Tawil syndrome
ICD-9 426.82, 794.31
OMIM 170390
DiseasesDB 700
MeSH D050030

WikiDoc Resources for Andersen-Tawil syndrome

Articles

Most recent articles on Andersen-Tawil syndrome

Most cited articles on Andersen-Tawil syndrome

Review articles on Andersen-Tawil syndrome

Articles on Andersen-Tawil syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Andersen-Tawil syndrome

Images of Andersen-Tawil syndrome

Photos of Andersen-Tawil syndrome

Podcasts & MP3s on Andersen-Tawil syndrome

Videos on Andersen-Tawil syndrome

Evidence Based Medicine

Cochrane Collaboration on Andersen-Tawil syndrome

Bandolier on Andersen-Tawil syndrome

TRIP on Andersen-Tawil syndrome

Clinical Trials

Ongoing Trials on Andersen-Tawil syndrome at Clinical Trials.gov

Trial results on Andersen-Tawil syndrome

Clinical Trials on Andersen-Tawil syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Andersen-Tawil syndrome

NICE Guidance on Andersen-Tawil syndrome

NHS PRODIGY Guidance

FDA on Andersen-Tawil syndrome

CDC on Andersen-Tawil syndrome

Books

Books on Andersen-Tawil syndrome

News

Andersen-Tawil syndrome in the news

Be alerted to news on Andersen-Tawil syndrome

News trends on Andersen-Tawil syndrome

Commentary

Blogs on Andersen-Tawil syndrome

Definitions

Definitions of Andersen-Tawil syndrome

Patient Resources / Community

Patient resources on Andersen-Tawil syndrome

Discussion groups on Andersen-Tawil syndrome

Patient Handouts on Andersen-Tawil syndrome

Directions to Hospitals Treating Andersen-Tawil syndrome

Risk calculators and risk factors for Andersen-Tawil syndrome

Healthcare Provider Resources

Symptoms of Andersen-Tawil syndrome

Causes & Risk Factors for Andersen-Tawil syndrome

Diagnostic studies for Andersen-Tawil syndrome

Treatment of Andersen-Tawil syndrome

Continuing Medical Education (CME)

CME Programs on Andersen-Tawil syndrome

International

Andersen-Tawil syndrome en Espanol

Andersen-Tawil syndrome en Francais

Business

Andersen-Tawil syndrome in the Marketplace

Patents on Andersen-Tawil syndrome

Experimental / Informatics

List of terms related to Andersen-Tawil syndrome

Cardiology Network

Discuss Andersen-Tawil syndrome further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Andersen-Tawil syndrome, also called Andersen syndrome and Long QT syndrome 7, is a form of long QT syndrome. It is a rare genetic disorder, and is inherited in an autosomal dominant pattern.

Presentation

Andersen-Tawil syndrome affects the heart, symptoms are a disruption in the rhythm of the heart's lower chambers (ventricular arrhythmia) in addition to the symptoms of long QT syndrome. There are also physical abnormalities associated with Andersen-Tawil syndrome, these typically affect the head, face, and limbs. These features often include an unusually small lower jaw (micrognathia), low-set ears, and an abnormal curvature of the fingers called clinodactyly.

Type 1 and type 2

Two types of Andersen-Tawil syndrome are distinguished by their genetic causes.

  • Type 1, which accounts for about 60 percent of all cases of the disorder, is caused by mutations in the KCNJ2 gene. [1][2]
  • The remaining 40 percent of cases are designated as type 2; the cause of the condition in these cases is unknown.

The protein made by the KCNJ2 gene forms a channel that transports potassium ions into muscle cells. The movement of potassium ions through these channels is critical for maintaining the normal functions of skeletal muscles which are used for movement and cardiac muscle. Mutations in the KCNJ2 gene alter the usual structure and function of potassium channels or prevent the channels from being inserted correctly into the cell membrane. Many mutations prevent a molecule called PIP2 from binding to the channels and effectively regulating their activity. These changes disrupt the flow of potassium ions in skeletal and cardiac muscle, leading to the periodic paralysis and irregular heart rhythm characteristic of Andersen-Tawil syndrome.

Researchers have not yet determined the role of the KCNJ2 gene in bone development, and it is not known how mutations in the gene lead to the developmental abnormalities often found in Andersen-Tawil syndrome.

Eponym

It is named for Ellen Andersen[3] and R. Tawil.[4][5]

References

  1. Tristani-Firouzi M, Jensen JL, Donaldson MR; et al. (2002). "Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)". J. Clin. Invest. 110 (3): 381–8. PMID 12163457.
  2. Pegan S, Arrabit C, Slesinger PA, Choe S (2006). "Andersen's syndrome mutation effects on the structure and assembly of the cytoplasmic domains of Kir2.1". Biochemistry. 45 (28): 8599–606. doi:10.1021/bi060653d. PMID 16834334.
  3. Andersen ED, Krasilnikoff PA, Overvad H (1971). "Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?". Acta paediatrica Scandinavica. 60 (5): 559–64. PMID 4106724.
  4. Tawil R, Ptacek LJ, Pavlakis SG; et al. (1994). "Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features". Ann. Neurol. 35 (3): 326–30. doi:10.1002/ana.410350313. PMID 8080508.
  5. Template:WhoNamedIt

Source

Template:SIB


Template:WikiDoc Sources